Related Experiment Videos
Confidence interval estimation for DNA and mRNA concentration by real-time PCR: A new environment for an old theorem
P Verderio1, C Orlando, C Casini Raggi
1Operative Unit of Medical Statistics and Biometry, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. paolo.verderio@istitutotumori.mi.it
The International Journal of Biological Markers
|April 14, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Assessment of Clinical and Neurological Alterations Before Radiation Therapy in Children With Malignant Brain Tumours.
Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Reliability of core needle biopsy for HER2-low early-stage breast cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.
Breast cancer research and treatment·2024
Single-cell multi-omics reveals NUF2 as a potential biomarker associated with the high-lactylation malignant state in osteosarcoma.
The International journal of biological markers·2026
The diagnostic and predictive value of miR-145-3p in gastric cancer and its regulation of gastric cancer progression via targeting CREB1.
The International journal of biological markers·2026
PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer.
The International journal of biological markers·2026
Luminex assay of plasma IL-6, TNF-α, leptin, and adiponectin: Impact of anticoagulants, single-well analysis, and freeze-thaw stability.
The International journal of biological markers·2026
Association of NF-kappaBIA rs696 gene polymorphism with breast cancer risk in Bangladeshi women: A case-control study.
The International journal of biological markers·2026
Circulating tumor cells and tumor-derived cell-free DNA in cancer management: Clinical evidence, limitations, and future directions.
The International journal of biological markers·2026
Model Gateway: Management platform for model-driven drug discovery.
Drug discovery today·2026
Structure-aware deep learning enhances m6A prediction and reveals cell type-associated RNA structural signatures.
PLoS computational biology·2026
Adversarial Purification by Consistency-aware Latent Space Optimization on Data Manifolds.
IEEE transactions on pattern analysis and machine intelligence·2026